Cargando…

Functionalized Metal Nanoparticles in Cancer Therapy

Currently, there are many studies on the application of nanotechnology in therapy. Metallic nanoparticles are promising nanomaterials in cancer therapy; however, functionalization of these nanoparticles with biomolecules has become relevant as their effect on cancer cells is considerably increased b...

Descripción completa

Detalles Bibliográficos
Autores principales: Villalobos Gutiérrez, Paola Trinidad, Muñoz Carrillo, José Luis, Sandoval Salazar, Cuauhtémoc, Viveros Paredes, Juan Manuel, Gutiérrez Coronado, Oscar
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10383728/
https://www.ncbi.nlm.nih.gov/pubmed/37514119
http://dx.doi.org/10.3390/pharmaceutics15071932
_version_ 1785080982409314304
author Villalobos Gutiérrez, Paola Trinidad
Muñoz Carrillo, José Luis
Sandoval Salazar, Cuauhtémoc
Viveros Paredes, Juan Manuel
Gutiérrez Coronado, Oscar
author_facet Villalobos Gutiérrez, Paola Trinidad
Muñoz Carrillo, José Luis
Sandoval Salazar, Cuauhtémoc
Viveros Paredes, Juan Manuel
Gutiérrez Coronado, Oscar
author_sort Villalobos Gutiérrez, Paola Trinidad
collection PubMed
description Currently, there are many studies on the application of nanotechnology in therapy. Metallic nanoparticles are promising nanomaterials in cancer therapy; however, functionalization of these nanoparticles with biomolecules has become relevant as their effect on cancer cells is considerably increased by photothermal and photodynamic therapies, drug nanocarriers, and specificity by antibodies, resulting in new therapies that are more specific against different types of cancer. This review describes studies on the effect of functionalized palladium, gold, silver and platinum nanoparticles in the treatment of cancer, these nanoparticles themselves show an anticancer effect. This effect is further enhanced when the NPs are functionalized with either antibodies, DNA, RNA, peptides, proteins, or folic acid and other molecules. These NPs can penetrate the cell and accumulate in the tumor tissue, resulting in a cytotoxic effect through the generation of ROS, the induction of apoptosis, cell cycle arrest, DNA fragmentation, and a photothermal effect. NP-based therapy is a new strategy that can be used synergistically with chemotherapy and radiotherapy to achieve more effective therapies and reduce side effects.
format Online
Article
Text
id pubmed-10383728
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher MDPI
record_format MEDLINE/PubMed
spelling pubmed-103837282023-07-30 Functionalized Metal Nanoparticles in Cancer Therapy Villalobos Gutiérrez, Paola Trinidad Muñoz Carrillo, José Luis Sandoval Salazar, Cuauhtémoc Viveros Paredes, Juan Manuel Gutiérrez Coronado, Oscar Pharmaceutics Review Currently, there are many studies on the application of nanotechnology in therapy. Metallic nanoparticles are promising nanomaterials in cancer therapy; however, functionalization of these nanoparticles with biomolecules has become relevant as their effect on cancer cells is considerably increased by photothermal and photodynamic therapies, drug nanocarriers, and specificity by antibodies, resulting in new therapies that are more specific against different types of cancer. This review describes studies on the effect of functionalized palladium, gold, silver and platinum nanoparticles in the treatment of cancer, these nanoparticles themselves show an anticancer effect. This effect is further enhanced when the NPs are functionalized with either antibodies, DNA, RNA, peptides, proteins, or folic acid and other molecules. These NPs can penetrate the cell and accumulate in the tumor tissue, resulting in a cytotoxic effect through the generation of ROS, the induction of apoptosis, cell cycle arrest, DNA fragmentation, and a photothermal effect. NP-based therapy is a new strategy that can be used synergistically with chemotherapy and radiotherapy to achieve more effective therapies and reduce side effects. MDPI 2023-07-11 /pmc/articles/PMC10383728/ /pubmed/37514119 http://dx.doi.org/10.3390/pharmaceutics15071932 Text en © 2023 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/).
spellingShingle Review
Villalobos Gutiérrez, Paola Trinidad
Muñoz Carrillo, José Luis
Sandoval Salazar, Cuauhtémoc
Viveros Paredes, Juan Manuel
Gutiérrez Coronado, Oscar
Functionalized Metal Nanoparticles in Cancer Therapy
title Functionalized Metal Nanoparticles in Cancer Therapy
title_full Functionalized Metal Nanoparticles in Cancer Therapy
title_fullStr Functionalized Metal Nanoparticles in Cancer Therapy
title_full_unstemmed Functionalized Metal Nanoparticles in Cancer Therapy
title_short Functionalized Metal Nanoparticles in Cancer Therapy
title_sort functionalized metal nanoparticles in cancer therapy
topic Review
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10383728/
https://www.ncbi.nlm.nih.gov/pubmed/37514119
http://dx.doi.org/10.3390/pharmaceutics15071932
work_keys_str_mv AT villalobosgutierrezpaolatrinidad functionalizedmetalnanoparticlesincancertherapy
AT munozcarrillojoseluis functionalizedmetalnanoparticlesincancertherapy
AT sandovalsalazarcuauhtemoc functionalizedmetalnanoparticlesincancertherapy
AT viverosparedesjuanmanuel functionalizedmetalnanoparticlesincancertherapy
AT gutierrezcoronadooscar functionalizedmetalnanoparticlesincancertherapy